To further determine the underlying mechanism by which the EFNB2/EPHB4 axis contributes to CRC LM, we conducted a Gene Set Enrichment Analysis (GSEA) analysis based on EFNB2 expression in the CRC LM samples. The gene discussed is EFNB2; the disease is colorectal carcinoma.